Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans

Arch Ophthalmol. 1999 May;117(5):673-4. doi: 10.1001/archopht.117.5.673.
No abstract available

Publication types

  • Editorial
  • Research Support, U.S. Gov't, P.H.S.
  • Review
  • Comment

MeSH terms

  • Administration, Topical
  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic alpha-Agonists / pharmacology*
  • Aqueous Humor / metabolism*
  • Brimonidine Tartrate
  • Clonidine / administration & dosage
  • Clonidine / analogs & derivatives*
  • Clonidine / pharmacology
  • Drug Synergism
  • Humans
  • Intraocular Pressure / drug effects*
  • Latanoprost
  • Ophthalmic Solutions / administration & dosage
  • Ophthalmic Solutions / pharmacology
  • Prostaglandins F, Synthetic / administration & dosage
  • Prostaglandins F, Synthetic / pharmacology
  • Quinoxalines / administration & dosage
  • Quinoxalines / pharmacology*
  • Timolol / administration & dosage
  • Timolol / pharmacology

Substances

  • Adrenergic alpha-Agonists
  • Ophthalmic Solutions
  • Prostaglandins F, Synthetic
  • Quinoxalines
  • Brimonidine Tartrate
  • Latanoprost
  • Timolol
  • apraclonidine
  • Clonidine